Literature DB >> 20044657

Risk of developing dementia in people with diabetes and mild cognitive impairment.

Latha Velayudhan1, Michaela Poppe, Nicola Archer, Petroula Proitsi, Richard G Brown, Simon Lovestone.   

Abstract

BACKGROUND: Diabetes mellitus is associated with cognitive dysfunction, but it is not clear whether the disorder increases the risk of conversion from mild cognitive impairment to dementia. AIMS: To determine the association between diabetes mellitus and dementia conversion in people with mild cognitive impairment (Peterson's criteria) in a prospective community-based study.
METHOD: People over 65 years old were approached through primary care practices in south London, UK, and those with mild cognitive impairment (n = 103) were followed up for 4 years. Presence of diabetes was established from self-report and information from general practitioners.
RESULTS: Nineteen participants progressed to dementia, with the predominant diagnosis being probable or possible Alzheimer's disease (in 84%). Only diabetes mellitus was associated with progression to dementia (hazard ratio 2.9, 95% CI 1.1-7.3) after adjustment for sociodemographic factors, APOE4, premorbid IQ and other health conditions.
CONCLUSIONS: Diabetes mellitus increases not only the risks of dementia and mild cognitive impairment but also the risk of progression from such impairment to dementia.

Entities:  

Mesh:

Year:  2010        PMID: 20044657     DOI: 10.1192/bjp.bp.109.067942

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  47 in total

Review 1.  Metabolic reserve as a determinant of cognitive aging.

Authors:  Alexis M Stranahan; Mark P Mattson
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Food for thought: the role of appetitive peptides in age-related cognitive decline.

Authors:  Jim R Fadel; Corinne G Jolivalt; Lawrence P Reagan
Journal:  Ageing Res Rev       Date:  2013-02-13       Impact factor: 10.895

4.  Impaired glycemia increases disease progression in mild cognitive impairment.

Authors:  Jill K Morris; Eric D Vidoni; Robyn A Honea; Jeffrey M Burns
Journal:  Neurobiol Aging       Date:  2013-10-23       Impact factor: 4.673

Review 5.  Bidirectional metabolic regulation of neurocognitive function.

Authors:  Alexis M Stranahan; Mark P Mattson
Journal:  Neurobiol Learn Mem       Date:  2011-01-12       Impact factor: 2.877

6.  The serum metabolomics signature of type 2 diabetes is obscured in Alzheimer's disease.

Authors:  Jill K Morris; Brian D Piccolo; Kartik Shankar; John P Thyfault; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-12-26       Impact factor: 4.310

7.  Assessment of the cognitive status in diabetes mellitus.

Authors:  Shuba N
Journal:  J Clin Diagn Res       Date:  2012-09-12

Review 8.  Is Alzheimer's disease a systemic disease?

Authors:  Jill K Morris; Robyn A Honea; Eric D Vidoni; Russell H Swerdlow; Jeffrey M Burns
Journal:  Biochim Biophys Acta       Date:  2014-04-18

9.  Clinical Characteristics for the Relationship between Type-2 Diabetes Mellitus and Cognitive Impairment: A Cross-Sectional Study.

Authors:  Yi Zhou; Rong Fang; Li-Hua Liu; Sheng-Di Chen; Hui-Dong Tang
Journal:  Aging Dis       Date:  2015-08-01       Impact factor: 6.745

10.  Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189.

Authors:  Corinne G Jolivalt; Alexandra Marquez; David Quach; Michelle C Navarro Diaz; Carlos Anaya; Betelhem Kifle; Nabeel Muttalib; Gabriela Sanchez; Lucy Guernsey; Mike Hefferan; Darrel R Smith; Paul Fernyhough; Karl Johe; Nigel A Calcutt
Journal:  Diabetes       Date:  2019-09-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.